Supply of Medicinal Products with Erdafitinib, Daunorubicin with Cytarabine, and Mirikizumab
Status
Active
Submission Deadline
32 days remaining
Contracting authority
Fakultní nemocnice Hradec Králové14 more open tenders view
Location
Hradec Králové - Nový Hradec Králové, Czechia
Estimated Value
CZK 28,428,600
Procedure
Open Procedure · Supplies
Category
Antineoplastic agents.
Published
Reference
ted-611674-2026
Source
Supply of medicinal products containing the active ingredients erdafitinib, daunorubicin with cytarabine, and mirikizumab. Deliveries are continuous over 4 years for erdafitinib and daunorubicin with cytarabine, and until September 18, 2029, for mirikizumab, each according to current needs.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 611674-2026HTML
- TED PDF — 611674-2026PDF
- TED XML — 611674-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Lots (3)
- LOT-0001Arzneimittel mit ErdafitinibCZK 28,428,600
- LOT-0002Arzneimittel mit Daunorubicin und Cytarabin€7,253,930
- LOT-0003Arzneimittel mit Mirikizumab€12,849,270
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024